About: Butylscopolamine Bromide

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Butylscopolamine Bromide Goto Sponge Distinct Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	Class
rdfs:label	Butylscopolamine Bromide
rdfs:subClassOf	Antispasmodic Agent Antimuscarinic Agent
Has_Free_Acid_Or_Base_Form	Butylscopolamine
Concept_In_Subset	FDA Established Names and Unique Ingredient Identifier Codes Terminology
Semantic_Type	Pharmacologic Substance
Preferred_Name	Butylscopolamine Bromide
UMLS_CUI	C0006519
CAS_Registry	149-64-4
FDA_UNII_Code	0GH9JX37C8
Contributing_Source	FDA
PDQ_Open_Trial_Search_ID	690309
PDQ_Closed_Trial_Search_ID	690309
Chemical_Formula	C21H30NO4.Br
Legacy_Concept_Name	Butylscopolamine_Bromide
FULL_SYN	Butylscopolamine BromidePTNCI Oral Hyoscine ButylbromideSYNCI BUTYLSCOPOLAMINE BROMIDEPTFDA0GH9JX37C8 BuscopanSYNCI
DEFINITION	An orally available bromide salt form of butylscopolamine, a quaternary ammonium derivative of the alkaloid scopolamine, with anticholinergic property. Upon oral administration, hyoscine butylbromide binds to and blocks muscarinic receptors located on postganglionic parasympathetic nerve endings and on smooth muscle cells. This blocks the activity of acetylcholine (Ach) and causes its antispasmodic effect in the gastrointestinal (GI), urinary, uterine, and biliary tracts. This agent may also facilitate radiologic visualization of the GI tract.NCI
code	C65277
is Has_Salt_Form of	Butylscopolamine

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 46 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software